Trials / Recruiting
RecruitingNCT06307275
Intermittent Fasting on Body Fat and Quality of Life
The Effect of Intermittent Fasting on Body Fat and Quality of Life
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this investigator-initiated study to check the feasibility that intermittent fasting has on body fat loss and quality of life.
Detailed description
Start of study: Informed Consent, Body Fat Analysis, Questionnaires on quality of life, sleep, and stress. For the next four weeks, participants will eat their normal food intake with no restrictions on when to eat. Participants will keep their normal weekly exercise routine. Midway of study: Body Fat Analysis, Questionnaires on quality of life, sleep, and stress. For the next four weeks, participants will do the intermittent fasting program. This program has participants fasting 16 hours from their last meal of the previous evening's meal to the first meal of their next day. Then for 8 hours, participants are able to eat. During the fasting, participants are allowed to consume water and black coffee/tea. Participants will also keep their normal weekly exercise routine. End of study: Body Fat Analysis, Questionnaires on quality of life, sleep, and stress.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fasting | Fasting for 16 hours from participant last meal of the previous evening's meal to the first meal of the next day. Then for 8 hours, participant is able to eat. During the fasting, participants are allowed to consume water and black coffee/tea. Participants will also keep their normal weekly exercise routine. |
| OTHER | non fasting | Participants will not be fasting during these four weeks. They will eat their normal food intake and keep their normal physical activity levels. |
Timeline
- Start date
- 2024-03-11
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-03-12
- Last updated
- 2025-04-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06307275. Inclusion in this directory is not an endorsement.